Related Experiment Video
Updated: Jul 22, 2026
14:06
Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays
Published on: November 12, 2012
Colicins G and H and their host strains
1Faculty of Medicine, Memorial University of Newfoundland, St. John's, Canada.
Canadian Journal of Microbiology
|October 1, 1991
Summary
Two novel colicin proteins, weighing approximately 5,500 and 100,000 Daltons, were identified in Escherichia coli strains. These colicins exhibit unique resistance properties and structural characteristics.
Area of Science:
- Microbiology
- Bacteriology
- Molecular Biology
Background:
- Escherichia coli produces various colicins, which are bactericidal proteins crucial for bacterial competition.
- Understanding colicin diversity and properties is essential for microbial ecology and potential therapeutic applications.
Purpose of the Study:
- To characterize novel colicin proteins synthesized by Escherichia coli strains CA46(pColG) and CA58(pColH).
- To investigate the biochemical and immunological properties of these newly identified colicins.
Main Methods:
- Bactericidal activity assays were performed to detect colicin production.
- Protein molecular weights were estimated using SDS-PAGE.
- Protease resistance (trypsin) was assessed.
- Serotyping and selection of rough variants were conducted.
- Bacteriophage receptor binding assays were utilized.
Main Results:
- Two distinct colicin proteins, approximately 5,500 and 100,000 Daltons, were identified in strains CA46(pColG) and CA58(pColH).
- These colicins demonstrated enhanced resistance to trypsin compared to colicins A, D, E1, and V.
- Wild-type strains showed intrinsic resistance to multiple colicins, limiting their use for colicin identification via immunity.
- O antigenic side chains of wild-type strains partially masked bacteriophage receptors.
Conclusions:
- Escherichia coli strains CA46 and CA58 synthesize unique colicin G and H proteins with distinct molecular weights and protease resistance.
- The serotype and O antigenic side chains of these strains influence their interaction with other colicins and bacteriophages.
- The identified colicins represent novel additions to the known colicin repertoire, warranting further investigation.
Related Concept Videos
01:23Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
01:12Bacterial Toxins
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
01:28Regulation of Bacterial Virulence
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...